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MeCP2 is a chromatin-associated protein that is mutated in Rett syndrome.
Its methyl-CpG-binding domain interacts with DNA containing methylated
cytosine, but other modes of recruitment to the genome have also been pro-
posed. Here, we use in vitro and in vivo assays to investigate the DNA binding
specificity of two AT-hook motifs in MeCP2. One exhibits robust sequence-
specific DNA binding, whereas the other is a much weaker AT-hook. Our data
indicate that these motifs are secondary contributors to DNA binding by
MeCP2, and this view is supported by the absence of disease-causing missense
mutations at these sites.
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Rett syndrome (RTT) is a severe neurological disor-
der caused by mutations in the X-linked gene encod-
ing the methyl-CpG-binding protein MECP2 [1]. It
affects approximately 1 in 10 000 females, but is
much rarer in males, where loss-of-function muta-
tions give rise to a severe neonatal encephalopathy
and early death. MeCP2 is a chromatin-associated
protein that contains a methyl-CpG-binding domain
(MBD) [2,3]. Much evidence suggests that the MBD
is the primary mediator of MeCP2 binding to the
genome. Firstly, the MBD binds to DNA in vitro in
a manner that is highly specific for sequences con-
taining methylated cytosine [3–5]. Secondly, chro-
matin immunoprecipitation analysis of MeCP2 in the
brain revealed preferential binding to methylated
sequences, and peaks of MeCP2 binding at sites of
cytosine methylation [4–6]. Thirdly, genetic ablation
of DNA methylation in embryonic stem cells led to
a widespread redistribution of MeCP2 bound to the
genome [7]. Finally, the crystal structure of the
MBD bound to DNA has been solved, and this
revealed the atomic details of how methylated sites
are recognized [8].
The finding that deletion of the DNA methyltrans-
ferases leads to MeCP2 redistribution along the gen-
ome, rather than release from chromatin [7], suggests
that DNA binding is not purely methylation-depen-
dent and MBD-mediated. Indeed, other modes of
MeCP2 binding to the genome have been proposed.
For example, the MBD of chicken MeCP2 has been
shown to interact in vitro with specific unmodified
DNA sequences [9]. Furthermore, three AT-hook
motif sequences have been proposed to exist in MeCP2
[2,10]. AT-hooks are short DNA-binding motifs, which
interact with the wide minor groove of AT-rich
sequences via the core consensus amino acid sequence
RGRP [11–13]. The sequence of the first of these
motifs, AT-hook 1 (amino acids 184-195), was identi-
fied in the initial report on MeCP2 [2], but is unchar-
acterized experimentally and of unknown functional
significance. Sequences including the second, AT-hook
2 (amino acids 264-273), are involved in determining
Abbreviations
MBD, methyl-CpG-binding domain; NID, NCoR/SMRT interaction domain; RTT, Rett syndrome.
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the clinical severity of different RTT truncation muta-
tions [10]. DNA binding by this motif has been
reported, but sequence specificity has yet to be
explored [10]. A third motif, AT-hook 3 (amino acids
341-364), has also been proposed to exist in MeCP2
[10]. However, unlike AT-hooks 1 and 2, this motif
has not been annotated by InterPro (http://www.ebi.
ac.uk/interpro/). It also contains inserted sequences,
which disrupt the RGRP core motif [10], and are likely
to prevent DNA binding.
In this study, we assess the DNA binding specificity
of the two InterPro-annotated MeCP2 AT-hooks
using both in vitro and in vivo techniques. We report
that AT-hook 1 shows a pronounced preference for
AT-rich DNA, whereas AT-hook 2 has weaker AT-
hook character. Both motifs bind to AT-rich DNA
much less strongly than a consensus AT-hook motif
derived from the high mobility group HMG-I proteins
[12]. In mouse cells, most residual binding of MeCP2
to AT-rich heterochromatin, in the absence of a func-
tional MBD, is attributable to these two motifs. In
agreement with the biochemical analyses, AT-hook 1
makes a greater contribution to in vivo binding than
AT-hook 2. Consistent with the AT-hooks being
minor contributors to DNA binding is the absence of
mutations causing RTT-related disorders in these
motifs.
Materials and methods
Cell imaging
The EGFP-MeCP2 expression plasmid has been previously
described [14]. The AT-hook 1 mutation in this vector has
also been described [14]. Where indicated, F155S and R268Q
or R270X mutations were introduced into this construct to
inactivate the MBD and AT-hook 2, respectively. NIH-3T3
cells were seeded on coverslips in six-well plates and trans-
fected with JetPei (Polyplus, Strasbourg, France). After 48 h,
cells were fixed for 15 min in 4% paraformaldehyde before
being stained with DAPI and mounted with Prolong Gold
(Life Technologies). Slides were photographed on a Leica
SP5 Confocal microscope at 609 magnification and 50–130
nuclei were counted for each transfection, blind to the identity
of the transfected plasmid.
Electrophoretic mobility shift assay
Oligonucleotides encoding MeCP2 AT-hook 1 (GTGRGR
GRPKGSG), AT-hook 2 (AEADPQAIPKKRGRKP) and
the AT-hook consensus sequence from HMG-I (TPK
RPRGRPKK) were cloned between the EcoRI and NotI
sites of pGEX-4T-1. Recombinant proteins were expressed
in E.coli BL21(DE3)pLysS and purified using glutathione
sepharose (GE Healthcare) essentially as described else-
where [10]. A 20lL reaction mix was assembled in Elec-
trophoretic mobility shift assay (EMSA) buffer (10 mM
Tris-HCl pH 7.5, 50 mM KCl, 0.5 mM MgCl2, 0.1 mM
EDTA, 0.1 mgmL1 BSA, and 5% glycerol) with poly
(dA-dT) or poly(dG-dC) (Sigma) as a competitor DNA at
the indicated concentrations. Protein concentration was 40
lM for GST alone and MeCP2 AT-hooks 1 and 2, and
1.5 lM for the HMG-I AT-hook. As probe, we used 0.5 ng
of a 32P-end-labeled restriction fragment derived from the
mouse major satellite [2]. Complexes were incubated on ice
for 30 min, and then resolved by electrophoresis on native
6% acrylamide gels. Competition levels were visualized by
phosphorimager analysis and quantified using ImageJ
(NIH, Bethesda, MD, USA). Experiments were performed
in duplicate.
Results
Sequence-specific DNA binding by MeCP2
AT-hook motifs in vitro
To better characterize the determinants of DNA bind-
ing by MeCP2, we expressed peptides corresponding
to AT-hooks 1 and 2 of MeCP2 (Fig. 1A) as GST
fusion proteins (Fig. 1B) and performed EMSAs. A
consensus AT-hook motif derived from the HMG-I
proteins was also used as a comparator [12]. We used
a radio-labeled probe derived from AT-rich mouse
satellite DNA (Fig. 1C), and sequence specificity was
established by competition with unlabeled poly(dA-dT)
or poly(dG-dC). Both AT-hook 1 and AT-hook 2
from MeCP2 were able to form complexes with the
probe, but binding required approximately 25-fold
more protein than was needed with the control motif
from HMG-I (see Materials and Methods), indicating
much weaker binding to DNA. Poly(dA-dT), but not
poly(dG-dC), effectively abolished binding by both the
control AT-hook from HMG-I, and AT-hook 1 from
MeCP2, suggesting that these peptides do indeed bind
preferentially to AT-rich DNA. Binding by AT-hook
2, on the other hand, was only minimally inhibited by
competitor DNA, and poly(dA-dT) interfered with
binding only slightly more efficiently than poly(dG-
dC), suggesting that this peptide has much poorer
AT-hook character (Fig. 1D).
To further investigate the sequence specificity of
DNA binding by MeCP2 AT-hooks 1 and 2, we per-
formed EMSAs using a range of concentrations of poly
(dA-dT) or poly(dG-dC) competitor DNA (Fig. 1E).
The results confirmed that AT-hook 1 is much more
sensitive to competition from poly(dA-dT) than poly
(dG-dC), whereas the differential effects of the two
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Fig. 1. MeCP2 AT-hooks 1 and 2 show specific affinity for AT-rich DNA. (A) Domains and features of MeCP2. AT-hook 1 (blue), AT-hook 2
(green), AT-hook 3 (black), the F155 residue (red) in the methyl-CpG-binding domain (MBD) (dark gray) and the NCoR/SMRT Interaction
Domain (NID) (hatched box) are highlighted. (B) Fusion proteins between glutathione-S-transferase (GST) and AT-hook containing peptides
from HMG-I, or MeCP2 AT-hook 1 or 2. Arginine residues in red were mutated in the full-length protein for imaging experiments (see
Fig. 2). (C) Sequence of EMSA probe (234 base pairs) corresponding to mouse major satellite DNA. AT-tracts >4 nucleotides in length are
shown in red. (D) EMSAs showing effect of competition (comp.) by unlabeled poly(dA-dT) (AT) or poly(dG-dC) (GC) on protein–DNA
complexes. Lane p contains probe alone. (E) Comparing the effects of varying amounts of AT or GC competitor on complexes between AT-
hook 1 or AT-hook 2 and major satellite DNA probe. (F) Quantification of EMSA data from previous panel. Competition with poly(dA-dT) is
indicated with unbroken lines and competition with poly(dG-dC) by dotted lines.
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competitors on AT-hook 2 were very subtle by compar-
ison (Fig. 1F). For example, 0.8 lg of poly(dA-dT) dis-
placed approximately two-thirds of the probe bound by
AT-hook 1, but only one-fifth of the probe bound to
AT-hook 2 (Fig. 1F). On the other hand, the effects of
poly(dG-dC), a control DNA, were very similar for
both AT-hooks 1 and 2 (Fig. 1E,F). Thus, by varying
competitor DNA concentrations, we were able to reveal
a weak AT-hook character of the AT-hook 2 motif from
MeCP2. Finally, we performed a control EMSA experi-
ment using GST alone. The specificity of our assay was
confirmed since this protein failed to bind to the major
satellite probe DNA (Fig. S1). Collectively, our data
suggest that both AT-hook 1 and AT-hook 2 of MeCP2
show specificity for binding to AT-rich DNA, but both
bind less efficiently than the consensus motif from
HMG-I, and furthermore, AT-hook 2 has substantially
weaker AT-hook character than AT-hook 1.
Heterochromatin binding by MeCP2 AT-hook
motifs in vivo
So far, our experiments have been restricted to an
in vitro analysis of short fragments of MeCP2. To inves-
tigate the significance of these motifs in vivo in the con-
text of the full-length protein, we developed an assay
based on the expression of MeCP2 as an EGFP fusion
protein in mouse NIH-3T3 cells. In mouse cells, wild-
type MeCP2 strongly localizes to the prominent hete-
rochromatic foci due to the presence of repetitive major
satellite DNA, which is both AT-rich and also contains
approximately 40% of the 5-methylcytosine in the gen-
ome [2]. Mutation of AT-hook 1 in the presence of a
functional MBD has previously been shown to have no
effect on the kinetics of chromatin binding by MeCP2
[14]. We therefore hypothesized that inactivating the
MBD of MeCP2 would be necessary to allow us to
assay any weak AT-hook-mediated residual binding to
the major satellite. To this end, we introduced into
MeCP2 the RTT-causing F155S mutation, which is pre-
dicted to lead to unfolding and inactivation of the MBD
[15]. Compared to wild-type EGFP-MeCP2, the mutant
protein produced a much more diffuse nuclear localiza-
tion (Fig. 2A). However, in approximately 60% of cells,
the EGFP-MeCP2F155S mutant protein still gave rise to
clear foci of fluorescence coinciding with heterochro-
matin (Fig. 2B). To ask whether these foci were due to
the AT-hook motifs in MeCP2, we mutated these
regions singly, or together, in the context of EGFP-
MeCP2F155S, and again assayed localization. Mutation
of AT-hook 1 reduced the number of nuclei with foci by
about 65%, whereas mutation of AT-hook 2 caused a
much smaller reduction that only reached statistical
significance in one replicate. Mutation of both AT-hook
motifs reduced the number of nuclei with foci by over
80% (Fig. 2B). We conclude that AT-hook 1 mediates
the majority of the residual heterochromatic localization
of MeCP2 remaining after the inactivation of the MBD,
with a smaller contribution by AT-hook 2. This finding
is consistent with our in vitro EMSA analysis of these
regions of MeCP2.
Finally, we wished to examine the effect of simultane-
ously mutating AT-hooks 1 and 2 on the localization of
MeCP2 carrying a wild-type MBD. Therefore, we
expressed EGFP-MeCP2 with a mutated AT-hook 1
and with a truncation (R270X) that inactivates
AT-hook 2 [10], and observed these cells by fluorescence
microscopy. As assessed by this assay, the double AT-
hook mutant MeCP2 localized correctly to heterochro-
matic foci (Fig. 2C). This observation is consistent with
the view that the AT-hooks of MeCP2 are not primary
determinants of its chromatin association.
AT-hook 1 and 2 mutations do not cause Rett
syndrome
MeCP2 is highly conserved among vertebrates. As well
as high levels of conservation in the MBD and the
NCoR/SMRT interaction domain (NID) [16], sequences
comprising AT-hooks 1 and 2 are identical between
humans and zebrafish, indicating that changes are delete-
rious and have been selected against (Fig. 3A). In this
case, mutations in the human population in these motifs
may be hypothesized to be associated with disease. A
mutation proximal to AT-hook 1 has been associated
with intellectual disability in males [17], but this muta-
tion (G185V) does not affect the core RGRP motif, and
is unlikely to strongly interfere with DNA binding. To
investigate whether MeCP2 AT-hook mutations are
compatible with proper brain function, or whether they
are associated with disease, we searched the human
exome aggregation consortium dataset (http://
exac.broadinstitute.org), for missense mutations that
would inactivate AT-hook 1 or 2. Males are particularly
sensitive to deleterious changes in the X-linked MECP2
gene, with those affected by severe RTT mutations gen-
erally not surviving beyond infancy. This dataset
excludes individuals with severe pediatric disorders, and
so the presence of males with the loss of the second argi-
nine of AT-hook 1, and the proline of AT-hook 2
(Fig. 3B), supports the view that DNA binding by these
motifs is not a critical aspect of MeCP2 funct-
ion. The presence of females with mutations in the
first arginine of AT-hook 1, and both arginine residues
of AT-hook 2 (Fig. 3B), is also consistent with this con-
clusion.
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Discussion
Our in vitro and in vivo data agree that AT-hook 1 of
MeCP2 is a robust AT-hook, whereas AT-hook 2 has
barely detectable, AT-hook character. In the case of
HMG-I, structural studies of two AT-hook motifs
revealed that proline residues, on each side of the
RGR core motif, position the peptide backbone away
from the minor groove. This allows residues
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Fig. 2. Residual chromatin binding is mediated mainly by MeCP2 AT-hook 1. (A) EGFP-MeCP2 was expressed in NIH-3T3 cells and
observed by fluorescence microscopy. MeCP2 was either wild-type (WT) or carrying the MBD mutation F155S (see Fig. 1A). Mutant
MeCP2 was also mutated (mut) at either AT-hook 1 or 2 (see Fig. 1B). Panels show examples of nuclei with strong localization to foci (WT),
diffuse localization with clearly visible heterochromatic foci (F155S with intact AT-hooks 1 and 2, and F155S with mut AT-hook 2) or diffuse
localization without detectable foci (F155S with mut AT-hook 1 and F155S with mut AT-hooks 1 and 2). (B) Counts of F155S transfected
nuclei with WT or mutant AT-hook 1 and/or AT-hook 2. In replicate experiments, counting was performed blind to the genotype of the
transfected constructs. Indicated p-values were calculated using Fisher’s exact test. (C) EGFP-MeCP2 with a mutation in AT-hook 1 as well
as a truncation (R270X) that abolishes AT-hook 2 was observed in NIH-3T3 cells. The wild-type MBD is sufficient to localize the protein to
heterochromatin.
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surrounding the motif to make stabilizing contacts
with the phosphate backbone of DNA [13,18]. We
hypothesize that, together with the nature of the
amino acids surrounding the core motif, the presence
and positioning of proline residues might account for
the weaker activity of MeCP2 AT-hook 2 than AT-
hook 1, and also for the weaker binding of both
motifs when compared with a canonical sequence from
HMG-I. In particular, AT-hook 1 contains the core
sequence RGRP but lacks an additional proline which
is adjacent and N-terminal. AT-hook 2 (RGRKP)
further lacks the proline which is immediately
C-terminal of RGR, and instead, a proline is found
one more residue distal (Fig. 3A).
As a mediator of the effects of DNA methylation
encoded by a gene that is mutated in a monogenic autism
spectrum disorder, MeCP2 has received considerable
attention. Specific disease-causing lesions in MeCP2 are
of particular interest since these allow connections to be
made between RTT pathology and MeCP2 biology.
Notably, RTT missense mutations primarily affect the
MBD and the NID, suggesting that these are two critical
interactions required for MeCP2 function [19]. Outside
of these domains, two disease-causing MeCP2 trunca-
tion mutations, G273X and R270X, which differ by the
presence and absence of key residues in the AT-hook 2
motif, give rise to milder and more severe pathologies,
respectively [10]. These results imply that despite its weak
AT-hook character, AT-hook 2 mediates an effect on
neurological function, which is discernible in the context
of a compromised truncated version ofMeCP2.
It is notable that no RTT-causing missense muta-
tions localize to either of the MeCP2 AT-hook motifs
investigated here. Examination of the human exome
aggregation consortium dataset also indicates that
mutations in AT-hooks 1 and 2 of MECP2 do not
contribute to RTT or X-linked intellectual disability.
Regions of MeCP2 that are not affected by RTT-caus-
ing missense mutations are nevertheless highly
conserved throughout the vertebrates, and this is true
of the AT-hook motifs examined in this report. This
constraint over millions of years of evolution strongly
implies that these regions have biological significance.
What then are the physiological roles of these AT-
hook motifs in MeCP2? A plausible scenario is that
AT-hooks 1 and 2 function as secondary DNA-bind-
ing domains, which either stabilize or modulate chro-
matin association by MeCP2. Alternatively, it is
possible that multifaceted interactions with DNA by
MeCP2 bring about chromatin compaction [10].
Future biochemical and genetic studies, in particular,
the creation of the appropriate cell or animal models
coupled with genome-wide chromatin immunoprecipi-
tation analysis, promise to shed light on the molecular
role of the AT-hook motifs in MeCP2.
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